The effect of excessive fat tissue on the measure of bone mineral density by dual X-ray absorptiometry: the impact of substantial weight loss following sleeve gastrectomy.


Journal

Clinical physiology and functional imaging
ISSN: 1475-097X
Titre abrégé: Clin Physiol Funct Imaging
Pays: England
ID NLM: 101137604

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 23 11 2018
accepted: 11 05 2019
pubmed: 16 5 2019
medline: 6 2 2020
entrez: 16 5 2019
Statut: ppublish

Résumé

Dual-energy X-ray absorptiometry (DXA) is used in clinical routine to determine areal bone mineral density (aBMD). However, it is not clear whether excessive fat mass or substantial weight loss modify the aBMD measurements. The aim of this study was to evaluate the effect of soft tissue composition on aBMD measured by DXA using a clinical model (i.e. sleeve gastrectomy: SG) that induces substantial body weight loss. Areal bone mineral density and body composition (fat mass: FM and lean tissue mass: LTM) were determined by DXA in 41 obese patients (33 women, 80.5%) just before SG and 1 month later. One month after SG, mean weight loss was -9.8 ± 2.6 kg, with a significant decrease in LTM and FM (kg) ranging from -7.3% to -9.5%. The relative variation in aBMD was increased at the lumbar spine (2.45 ± 3.44%) and decreased at the hip (-1.47 ± 2.28%), whereas no variation was observed for the whole body and radius. The variation in aBMD at the lumbar spine was inversely correlated with variations in weight, whole-body FM and trunk FM, but not LTM. This study shows evidence of a potential effect of body composition, particularly FM, on aBMD. However, given the modest change in aBMD, which was close to the precision error of aBMD measurements, it appears that significant weight loss does not have a clinically significant impact on the evaluation of aBMD using DXA.

Identifiants

pubmed: 31090241
doi: 10.1111/cpf.12584
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

345-354

Informations de copyright

© 2019 Scandinavian Society of Clinical Physiology and Nuclear Medicine. Published by John Wiley & Sons Ltd.

Auteurs

Laurent Maïmoun (L)

Service de Médecine Nucléaire, Hôpital Lapeyronie, Centre Hospitalier Régional Universitaire (CHRU) Montpellier et Université Montpellier (UM), Montpellier, France.
Physiologie et Médecine Expérimentale du Cœur et des Muscles (PhyMedExp), University of Montpellier, INSERM U1046, CNRS, UMR 9214, Montpellier Cedex 5, France.

Denis Mariano-Goulart (D)

Service de Médecine Nucléaire, Hôpital Lapeyronie, Centre Hospitalier Régional Universitaire (CHRU) Montpellier et Université Montpellier (UM), Montpellier, France.
Physiologie et Médecine Expérimentale du Cœur et des Muscles (PhyMedExp), University of Montpellier, INSERM U1046, CNRS, UMR 9214, Montpellier Cedex 5, France.

Audrey Jaussent (A)

Unité de Recherche Clinique, Biostatistiques et Epidémiologie, Département de l'Information Médicale, CHRU de Montpellier, Montpellier, France.

Patrick Lefebvre (P)

Departement d'Endocrinology, Diabetes, Nutrition, Hôpital Lapeyronie, CHRU Montpellier, Montpellier, France.

Marie-Christine Picot (MC)

Unité de Recherche Clinique, Biostatistiques et Epidémiologie, Département de l'Information Médicale, CHRU de Montpellier, Montpellier, France.

Krishna Mahadea (K)

Université de Montpellier, Montpellier, France.

Vincent Boudousq (V)

Service de Médecine Nucléaire, Hôpital Carémeau, Nîmes, France.

Clémence Fouillade (C)

Service de Chirurgie Digestive A, Hôpital Saint Eloi, CHRU Montpellier, Montpellier, France.

David Nocca (D)

Service de Chirurgie Digestive A, Hôpital Saint Eloi, CHRU Montpellier, Montpellier, France.

Fayçal Ben Bouallègue (F)

Service de Médecine Nucléaire, Hôpital Lapeyronie, Centre Hospitalier Régional Universitaire (CHRU) Montpellier et Université Montpellier (UM), Montpellier, France.
Physiologie et Médecine Expérimentale du Cœur et des Muscles (PhyMedExp), University of Montpellier, INSERM U1046, CNRS, UMR 9214, Montpellier Cedex 5, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH